Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemotherapy in extensive-stage small cell lung cancer: an exploratory biomarker analysis of a phase II study

Mengqing Xie, Chunxia Su, Xiaorong Dong et al.|Signal Transduction and Targeted Therapy|2025

Cited by 6